# Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

> **NCT06085716** · PHASE2,PHASE3 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 240 (estimated)

## Conditions studied

- Metastatic Cancers
- Fatigue

## Interventions

- **BEHAVIORAL:** Psychoeducational Intervention
- **DRUG:** Open Label Placebo
- **BEHAVIORAL:** Psychoeducational Intervention+Placebo

## Key facts

- **NCT ID:** NCT06085716
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-16
- **Primary completion:** 2027-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085716, "Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06085716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*